MSB 4.89% $1.07 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-690

  1. 3,347 Posts.
    lightbulb Created with Sketch. 792
    You guys are so friggin touchy.
    Just like when @ecool2 quit. (Bambi wasn’t shot, he chose to run away !!)
    We know MSB aren’t running the trial themselves.
    We know there is a pandemic and that hospitals and critical care are being overwhelmed etc etc etc.
    We know MSB are dealing with a bunch of other issues.
    I’m not having a crack at SI.
    I merely made the observation that this particular trial was earmarked to be fully enrolled by August at the latest as announced to the ASX. Now it’s due to be fully enrolled by January at the earliest.
    MSB and SI have had ample opportunity by way of updates and AGM etc to advise shareholders the reason for slipped timelines. SI would know exactly the reason.
    For whatever reason, MSB and SI have chosen not to say why.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.